AXIM Trademark

Trademark Overview

On Thursday, July 17, 2014, a trademark application was filed for AXIM with the United States Patent and Trademark Office. The USPTO has given the AXIM trademark a serial number of 86340652. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, September 18, 2020. This trademark is owned by AXIM Biotechnologies Inc.. The AXIM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science, laboratory testing, diagnostics, and pharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; pharmaceutical products development; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals for the treatment of age-related diseases, cancer, infectious diseases, mental illnesses, neurodegenerative diseases
axim

General Information

Serial Number86340652
Word MarkAXIM
Filing DateThursday, July 17, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, September 18, 2020
Registration Number4740903
Registration DateTuesday, May 19, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 9, 2014

Trademark Statements

Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science, laboratory testing, diagnostics, and pharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; pharmaceutical products development; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals for the treatment of age-related diseases, cancer, infectious diseases, mental illnesses, neurodegenerative diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 24, 2014
Primary Code042
First Use Anywhere DateFriday, August 1, 2014
First Use In Commerce DateSaturday, November 1, 2014

Trademark Owner History

Party NameAXIM Biotechnologies Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10111
Party NameAXIM Biotechnologies Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022
Party NameAXIM Biotechnologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Wednesday, October 29, 2014ASSIGNED TO EXAMINER
Monday, July 21, 2014NEW APPLICATION ENTERED
Thursday, July 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 7, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 7, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 7, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 8, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 8, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 9, 2014PUBLISHED FOR OPPOSITION
Monday, March 23, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 29, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 9, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 12, 2015TEAS STATEMENT OF USE RECEIVED
Thursday, February 12, 2015USE AMENDMENT FILED
Thursday, March 5, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 19, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 23, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 14, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 19, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, March 8, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 13, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 7, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 7, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 7, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 7, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 8, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 19, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 20, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 21, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 21, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 21, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 21, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 18, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 15, 2020TEAS SECTION 8 & 15 RECEIVED
Friday, September 18, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, May 19, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, September 18, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

axim development pharmaceutical research diseases pharmaceuticals biotechnology fields laboratory services related